Antonio Rueda

3.0k total citations
76 papers, 1.5k citations indexed

About

Antonio Rueda is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Antonio Rueda has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 32 papers in Pathology and Forensic Medicine and 20 papers in Molecular Biology. Recurrent topics in Antonio Rueda's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Antonio Rueda is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Antonio Rueda collaborates with scholars based in Spain, United Kingdom and United States. Antonio Rueda's co-authors include Michael Hackenberg, José Luis Tejera Oliver, Guillermo Barturen, Ricardo Lebrón, Cristina Gómez‐Martín, Emilio Alba, Mariano Provencio, Maximino Redondo, Elísabeth Pérez-Ruiz and Cristina Quero and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Antonio Rueda

72 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Rueda Spain 21 562 546 422 391 177 76 1.5k
Candice C. Black United States 20 431 0.8× 692 1.3× 269 0.6× 177 0.5× 263 1.5× 53 1.4k
Pauline Funchain United States 21 824 1.5× 614 1.1× 233 0.6× 177 0.5× 281 1.6× 111 1.8k
Salvatore Girlando Italy 19 879 1.6× 670 1.2× 343 0.8× 188 0.5× 207 1.2× 36 2.3k
Seiya Yokoyama Japan 22 362 0.6× 695 1.3× 252 0.6× 75 0.2× 162 0.9× 63 1.3k
Kerstin Haase Germany 11 544 1.0× 1.1k 2.0× 1.1k 2.5× 255 0.7× 335 1.9× 20 2.0k
Rajiv Raja United States 24 989 1.8× 930 1.7× 758 1.8× 337 0.9× 551 3.1× 59 2.3k
Danielle M. Hari United States 20 776 1.4× 1.0k 1.9× 548 1.3× 136 0.3× 397 2.2× 42 2.3k
S. Nicholas Agoff United States 21 835 1.5× 530 1.0× 481 1.1× 449 1.1× 456 2.6× 32 2.2k
Hongdo Do Australia 22 749 1.3× 1.2k 2.2× 864 2.0× 328 0.8× 702 4.0× 42 2.2k
G. Bea A. Wisman Netherlands 38 868 1.5× 1.8k 3.3× 719 1.7× 230 0.6× 241 1.4× 94 3.4k

Countries citing papers authored by Antonio Rueda

Since Specialization
Citations

This map shows the geographic impact of Antonio Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rueda more than expected).

Fields of papers citing papers by Antonio Rueda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rueda. The network helps show where Antonio Rueda may publish in the future.

Co-authorship network of co-authors of Antonio Rueda

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Rueda. A scholar is included among the top collaborators of Antonio Rueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Rueda. Antonio Rueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vavoulis, Dimitris, Nishita Thota, J. Howard Brown, et al.. (2025). Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals. Nature Communications. 16(1). 430–430. 9 indexed citations
2.
Ribelles, Nuria, Javier Pascual, José Carlos Benítez, et al.. (2024). Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study. JCO Global Oncology. 10(10). e2300363–e2300363. 6 indexed citations
3.
Jiménez, Begoña, Ana Godoy-Ortíz, Esperanza Torres, et al.. (2021). Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study. Cancers. 13(13). 3215–3215. 28 indexed citations
4.
Quero, Cristina, et al.. (2021). Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma. International Journal of Hematology. 115(1). 54–60. 1 indexed citations
5.
Pérez-Ruiz, Elísabeth, et al.. (2019). Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study. Supportive Care in Cancer. 27(4). 1279–1286. 20 indexed citations
6.
Collins, Graham P., Antonio Rueda, Gilles Salles, Bastian von Tresckow, & Francesco Zaja. (2018). Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries. Leukemia & lymphoma. 59(9). 2113–2120. 6 indexed citations
7.
Téllez, Teresa, Francisco Rivas‐Ruiz, Julia Alcaide, et al.. (2018). Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer. Cancer Research and Treatment. 50(4). 1270–1280. 12 indexed citations
8.
Ramchandren, Radhakrishnan, Michelle A. Fanale, Antonio Rueda, et al.. (2017). Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study. Blood. 130(Suppl_1). 651–651. 22 indexed citations
9.
Pérez-Ruiz, Elísabeth, Antonio Rueda, Francisco Rivas‐Ruiz, et al.. (2017). Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer. Pathology & Oncology Research. 24(4). 871–879. 3 indexed citations
10.
McMillan, Andrew, Alejandro Martı́n, Corinne Haïoun, et al.. (2016). Post Relapse Survival Rates in Diffuse Large B-Cell Lymphoma. Blood. 128(22). 4204–4204. 5 indexed citations
11.
López‐Guillermo, Armando, et al.. (2016). Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain. Applied Health Economics and Health Policy. 14(4). 465–477. 6 indexed citations
12.
Rueda, Antonio, Ramón García‐Sánz, Miguel Ángel Aguirre, et al.. (2015). A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma. Acta Oncologica. 54(6). 933–938. 11 indexed citations
13.
Rueda, Antonio, David Olmos, Luís Vicioso, et al.. (2014). Role of vascular endothelial growth factor C in classical Hodgkin lymphoma. Leukemia & lymphoma. 56(5). 1286–1294. 8 indexed citations
14.
Barturen, Guillermo, Antonio Rueda, José Luis Tejera Oliver, & Michael Hackenberg. (2013). MethylExtract: High-Quality methylation maps and SNV calling from whole genome bisulfite sequencing data. F1000Research. 2. 217–217. 35 indexed citations
15.
Alcaide, Julia, Antonio Rueda, Elísabeth Pérez-Ruiz, et al.. (2013). The role and prognostic value of apoptosis in colorectal carcinoma. BMC Clinical Pathology. 13(1). 24–24. 32 indexed citations
16.
López‐Guillermo, Armando, Dolores Caballero, Miguel Canales, et al.. (2011). Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma. Leukemia & lymphoma. 52(sup3). 1–14. 16 indexed citations
17.
Rueda, Antonio, P. Sabín, Juli Rifà, et al.. (2007). R‐CHOP‐14 in patients with diffuse large B‐cell lymphoma younger than 70 years: a multicentre, prospective study. Hematological Oncology. 26(1). 27–32. 13 indexed citations
18.
Fonseca, Emilio, Juan J. Grau, Javier Sastre, et al.. (2005). Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study. European Journal of Cancer. 41(9). 1254–1260. 16 indexed citations
19.
Rueda, Antonio, Isabel Sevilla, Josep Gumà, et al.. (2001). Secondary Prophylactic G-CSF (Filgrastim) Administration in Chemotherapy of Stage I and II Hodgkin's Lymphoma with ABVD. Leukemia & lymphoma. 41(3-4). 353–358. 14 indexed citations
20.
Navarro, Miguel, Ricard Mesı́a, Orland Dı́ez, et al.. (1997). Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women. Breast Cancer Research and Treatment. 42(1). 83–86. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candice C. Black Breakdown of academic impact, for papers by Pauline Funchain Breakdown of academic impact, for papers by Salvatore Girlando Breakdown of academic impact, for papers by Seiya Yokoyama Breakdown of academic impact, for papers by Kerstin Haase Breakdown of academic impact, for papers by Rajiv Raja Breakdown of academic impact, for papers by Danielle M. Hari Breakdown of academic impact, for papers by S. Nicholas Agoff Breakdown of academic impact, for papers by Hongdo Do Breakdown of academic impact, for papers by G. Bea A. Wisman
Rankless by CCL
2026